Contract facts
NONETO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII. is a federal NONE award for National Institutes Of Health Niaid held by Venatorx Pharmaceuticals, Inc. Estimated value $25M ($21.8M obligated). Current period of performance ends Jan 18, 2027. Last award drew 12 bidders. Place of performance: MALVERN, PA. Related solicitation HHS-NIH-NIAID-BAA2019-1.
TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Recompete timing
PublicCurrent PoP ends Jan 18, 2027 (133 days remaining). Agencies typically plan 12–18 months ahead — at 4.4 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordVenatorx Pharmaceuticals, Inc — $44.4M obligated across 6 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93020C00016?
75N93020C00016 (Advance a NOVEL beta-lactamase inhibitor of) is a National Institutes Of Health Niaid award with an estimated value of $25M, currently held by Venatorx Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93020C00016?
National Institutes Of Health Niaid awarded 75N93020C00016 to Venatorx Pharmaceuticals, Inc.
Who is the incumbent on 75N93020C00016?
Venatorx Pharmaceuticals, Inc is the incumbent with $44.4M across 6 related awards in SCOUT’s public footprint. The current period of performance ends Jan 18, 2027.
When does Venatorx Pharmaceuticals, Inc’s 75N93020C00016 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 18, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on 75N93020C00016 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.